e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by QuidelOrtho Corporation
QuidelOrtho Reports Third Quarter 2024 Financial Results
November 07, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho to Participate in Three Upcoming Investor Conferences
October 28, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho to Report Third Quarter 2024 Financial Results
October 17, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Announces New R&D Executive Leader
October 09, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer
September 10, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.
August 29, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho to Participate in Upcoming Investor Conferences
August 19, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Reports Second Quarter 2024 Financial Results
July 31, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho to Report Second Quarter 2024 Financial Results
July 17, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference
May 23, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Opens New Distribution Center in Pedricktown, NJ
May 15, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Reports First Quarter 2024 Financial Results
May 08, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer
May 02, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho To Report First Quarter 2024 Financial Results
April 17, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
April 10, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test
April 02, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada
March 06, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference
February 26, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Announces Changes in Executive Leadership
February 21, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results
February 13, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results
January 23, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 22, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay
December 20, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho to Participate in the Evercore ISI Conference
November 16, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Reports Third Quarter 2023 Financial Results
November 01, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
October 12, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
September 21, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 28, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Reports Second Quarter 2023 Financial Results
August 08, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row
July 25, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Tickers
QDEL
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Facebook
Twitter
YouTube